- Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
-
Kim B, Maverakis , Raychaudhuri SP
- KMID: 2456225
- Ann Dermatol.
- 2019 Oct;31(5):495-501.
- doi: 10.5021/ad.2019.31.5.495
Tumor necrosis factor (TNF) antagonists are highly effective treatments for psoriasis. These agents provide the opportunity to improve disease activity and achieve clinical remission. Despite its efficacy, long-term use of... -
- CITED
-
- Close
- SHARE
-
- Close
- No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
-
Wang JZ, Le S, Alexanian , Boddu S, Merleev A, Marusina A, Maverakis
- KMID: 2455408
- World J Mens Health.
- 2019 Sep;37(3):313-321.
- doi: 10.5534/wjmh.180050
PURPOSE: To examine the association between phosphodiesterase type 5 (PDE5) inhibitor use and melanoma by 1) conducting a systematic review of observational studies; and 2) determining if low PDE5A gene... -
- CITED
-
- Close
- SHARE
-
- Close
